Xu S - Search Results

1

An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme.

Ceccarelli DF, Tang X, Pelletier B, Orlicky S, Xie W, Plantevin V, Neculai D, Chou YC, Ogunjimi A, Al-Hakim A, Varelas X, Koszela J, Wasney GA, Vedadi M, Dhe-Paganon S, Cox S, Xu S, Lopez-Girona A, Mercurio F, Wrana J, Durocher D, Meloche S, Webb DR, Tyers M, Sicheri F. Ceccarelli DF, et al. Among authors: xu s. Cell. 2011 Jun 24;145(7):1075-87. doi: 10.1016/j.cell.2011.05.039. Epub 2011 Jun 16. Cell. 2011. PMID: 21683433 Free article.

2

Substrate recognition and ubiquitination of SCFSkp2/Cks1 ubiquitin-protein isopeptide ligase.

Xu S, Abbasian M, Patel P, Jensen-Pergakes K, Lombardo CR, Cathers BE, Xie W, Mercurio F, Pagano M, Giegel D, Cox S. Xu S, et al. J Biol Chem. 2007 May 25;282(21):15462-70. doi: 10.1074/jbc.M610758200. Epub 2007 Apr 4. J Biol Chem. 2007. PMID: 17409098 Free article.

3

In vitro SCFbeta-Trcp1-mediated IkappaBalpha ubiquitination assay for high-throughput screen.

Xu S, Patel P, Abbasian M, Giegel D, Xie W, Mercurio F, Cox S. Xu S, et al. Methods Enzymol. 2005;399:729-40. doi: 10.1016/S0076-6879(05)99048-4. Methods Enzymol. 2005. PMID: 16338392

4

A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase.

Matyskiela ME, Lu G, Ito T, Pagarigan B, Lu CC, Miller K, Fang W, Wang NY, Nguyen D, Houston J, Carmel G, Tran T, Riley M, Nosaka L, Lander GC, Gaidarova S, Xu S, Ruchelman AL, Handa H, Carmichael J, Daniel TO, Cathers BE, Lopez-Girona A, Chamberlain PP. Matyskiela ME, et al. Among authors: xu s. Nature. 2016 Jul 14;535(7611):252-7. doi: 10.1038/nature18611. Epub 2016 Jun 22. Nature. 2016. PMID: 27338790

5

Short-term lumbar disc and lumbar stability changes of one-hole split endoscope technique treatment of spinal stenosis.

Zhang J, Yan R, Xu S, Shao B, Dou Y. Zhang J, et al. Among authors: xu s. BMC Musculoskelet Disord. 2024 Apr 24;25(1):325. doi: 10.1186/s12891-024-07443-9. BMC Musculoskelet Disord. 2024. PMID: 38659005

6

Quantification of absolute labeling efficiency at the single-protein level.

Hellmeier J, Strauss S, Xu S, Masullo LA, Unterauer EM, Kowalewski R, Jungmann R. Hellmeier J, et al. Among authors: xu s. Nat Methods. 2024 Apr 24. doi: 10.1038/s41592-024-02242-5. Online ahead of print. Nat Methods. 2024. PMID: 38658647

7

Kalium channelrhodopsins effectively inhibit neurons.

Ott S, Xu S, Lee N, Hong I, Anns J, Suresh DD, Zhang Z, Zhang X, Harion R, Ye W, Chandramouli V, Jesuthasan S, Saheki Y, Claridge-Chang A. Ott S, et al. Among authors: xu s. Nat Commun. 2024 Apr 24;15(1):3480. doi: 10.1038/s41467-024-47203-w. Nat Commun. 2024. PMID: 38658537

8

Tumor-Tailored Ionizable Lipid Nanoparticles Facilitate IL-12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy.

Xu S, Xu Y, Solek NC, Chen J, Gong F, Varley AJ, Golubovic A, Pan A, Dong S, Zheng G, Li B. Xu S, et al. Adv Mater. 2024 Apr 24:e2400307. doi: 10.1002/adma.202400307. Online ahead of print. Adv Mater. 2024. PMID: 38657273

9

Multilabel Feature Selection via Shared Latent Sublabel Structure and Simultaneous Orthogonal Basis Clustering.

Shang R, Zhong J, Zhang W, Xu S, Li Y. Shang R, et al. Among authors: xu s. IEEE Trans Neural Netw Learn Syst. 2024 Apr 24;PP. doi: 10.1109/TNNLS.2024.3382911. Online ahead of print. IEEE Trans Neural Netw Learn Syst. 2024. PMID: 38656846

10

LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation.

Jiang Z, Huang Q, Chang Y, Qiu Y, Cheng H, Yang M, Ruan S, Ji S, Sun J, Wang Z, Xu S, Liang R, Dai X, Wu K, Li B, Li D, Zhao H. Jiang Z, et al. Among authors: xu s. Cell Oncol (Dordr). 2024 Apr 24. doi: 10.1007/s13402-024-00947-5. Online ahead of print. Cell Oncol (Dordr). 2024. PMID: 38656573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,544 results

Search Page